Abstract

The enzyme indoleamine 2,3-dioxygenase (IDO) contributes to immune tolerance in a variety of settings. In cancer IDO is expressed within the tumor itself as well as in antigen-presenting cells in tumor-draining lymph nodes, where it endorses the establishment of peripheral immune tolerance to tumor antigens. Recently, we described cytotoxic CD8(+) T-cell reactivity towards IDO-derived peptides.
OriginalsprogEngelsk
TidsskriftP L o S One
Vol/bind7
Udgave nummer4
Sider (fra-til)e34568
ISSN1932-6203
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase'. Sammen danner de et unikt fingeraftryk.

Citationsformater